Toxic and therapeutic effects of EMTP in obesity. - Suppr | 超能文献

Toxic and therapeutic effects of EMTP in obesity.

作者信息

Hollingsworth D R, Amatruda T T

出版信息

Clin Pharmacol Ther. 1969 Jul-Aug;10(4):540-2. doi: 10.1002/cpt1969104540.

DOI:10.1002/cpt1969104540

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Toxic and therapeutic effects of EMTP in obesity.

Clin Pharmacol Ther. 1969 Jul-Aug;10(4):540-2. doi: 10.1002/cpt1969104540.

2

Hypotensive effect of fenfluramine in the treatment of obesity.

Practitioner. 1971 Jul;207(237):101-5.

3

A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.

Curr Ther Res Clin Exp. 1970 Aug;12(8):502-15.

4

A comparative trial of fenfluramine and diethylpropion inbesity.芬氟拉明与二乙丙胺苯丙酮治疗肥胖症的对比试验。

Br J Clin Pract. 1970 Oct;24(10):423-5.

5

To the Editor: Fenfluramine (Poderax) for obesity.

S Afr Med J. 1969 Sep 27;43(39):1207.

6

Fenfluramine in obesity.

S Afr Med J. 1968 Jul 13;42(27):682.

7

Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.

Lancet. 1969 Dec 27;2(7635):1392-5. doi: 10.1016/s0140-6736(69)90935-0.

8

A treatment for refractory obesity using fenfluramine without dietary restriction.一种使用芬氟拉明治疗难治性肥胖且无需饮食限制的方法。

Br J Clin Pract. 1970 Jun;24(6):251-2.

9

Fenfluramine in the treatment of obesity.芬氟拉明治疗肥胖症。

Med J Aust. 1968 Nov 9;2(19):833-5. doi: 10.5694/j.1326-5377.1968.tb83230.x.

10

A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.氟苯丙胺与二乙丙胺苯丙酮治疗肥胖高血压患者的对照试验。

Br J Clin Pract. 1971 May;25(5):236-8.

引用本文的文献

1

Fenfluramine in the treatment of hypertensive patients with refractory obesity.芬氟拉明治疗难治性肥胖高血压患者。

Ulster Med J. 1975;44(1):56-61.

2

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.芬氟拉明：对其药理特性及在肥胖症治疗中的疗效综述。

Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001.

3

Bile acid, neutral sterol and faecal fat excretion in subjects treated with fenfluramine and its relationship to fenfluramine-induced diarrhoea.使用芬氟拉明治疗的受试者的胆汁酸、中性固醇和粪便脂肪排泄及其与芬氟拉明所致腹泻的关系。

Postgrad Med J. 1979 Mar;55(641):180-7. doi: 10.1136/pgmj.55.641.180.